DotScript est un chatbot IA spécialisé et gratuit, conçu pour les requêtes médicales et génétiques. Il propose deux bots distincts : un Bot Générique pour les questions quotidiennes sur la santé et les médicaments, et un Bot Génétique pour les questions avancées sur les maladies, les syndromes et la génétique. Il est rapide, fiable et ne nécessite aucune inscription, offrant un accès instantané à l'information médicale sur n'importe quel appareil.
Dr. Gupta est un chatbot médecin alimenté par l'IA qui fournit des informations instantanées et confidentielles sur la santé humaine et animale. Posez des questions sur les symptômes, les conditions et les médicaments. Il dispose d'une IA vétérinaire dédiée, Dr. McGrath, pour les requêtes liées aux animaux de compagnie. L'outil est conçu à des fins d'information et propose des forfaits gratuits et premium.
Aperçu du produit
DotScript Aperçu du produit
DotScript est un chatbot IA spécialisé et gratuit, conçu pour les requêtes médicales et génétiques. Il propose deux bots distincts : un Bot Générique pour les questions quotidiennes sur la santé et les médicaments, et un Bot Génétique pour les questions avancées sur les maladies, les syndromes et la génétique. Il est rapide, fiable et ne nécessite aucune inscription, offrant un accès instantané à l'information médicale sur n'importe quel appareil.
Dr. Gupta Aperçu du produit
Dr. Gupta est un chatbot médecin alimenté par l'IA qui fournit des informations instantanées et confidentielles sur la santé humaine et animale. Posez des questions sur les symptômes, les conditions et les médicaments. Il dispose d'une IA vétérinaire dédiée, Dr. McGrath, pour les requêtes liées aux animaux de compagnie. L'outil est conçu à des fins d'information et propose des forfaits gratuits et premium.
Detailed feature comparison
| Feature | DotScript | Dr. Gupta |
|---|---|---|
| Catégorie principale | Recherche | Assistant Médical |
| Ajouté | 2025-08-14 | 2025-08-08 |
| Tarification | Gratuit | Freemium |
| Site officiel | dotscript.netlify.app | www.drgupta.ai |
| Type de produit | Site web | Site web |
| Performance data | ||
| Note utilisateur | Non vérifié | Non vérifié |
| Commentaires | 0 | 0 |
| Visites mensuelles | 3.6K | 3.3K |
| Croissance mensuelle | Non vérifié | 28.1% |
| Favoris | 98 | 122 |
| Details | Voir les détails | Voir les détails |
DotScript vs Dr. Gupta monthly traffic
Compare DotScript and Dr. Gupta by monthly reach, traffic trend, visit depth, top regions, and acquisition sources.
How to interpret the traffic data
In the DotScript vs Dr. Gupta monthly traffic comparison, DotScript currently shows 3.6K visits and Dr. Gupta shows 3.3K; the two products have similar visible traffic, an absolute difference of about 264 visits. This reflects visible reach, not feature quality or paid users.
Only Dr. Gupta has complete third-party traffic details; DotScript uses visits recorded inside ToolMage. These scopes cannot estimate market share directly, and on-site views should not be treated as the product’s total website traffic.
DotScript monthly traffic:
Latest traffic
Dr. Gupta monthly traffic:
Latest traffic
Monthly traffic trend
- 2025/9: 10K Visites mensuelles
- 2026/1: 2.9K Visites mensuelles
- 2026/2: 1.7K Visites mensuelles
- 2026/3: 2.5K Visites mensuelles
- 2026/4: 2.6K Visites mensuelles
- 2026/5: 3.3K Visites mensuelles
Principales régions
Top 5 countries/regions
| Country/region | Percentage | Traffic |
|---|---|---|
| 🇺🇸United States | 77.34% | 2.6K |
| 🇮🇳India | 22.66% | 747 |
Mots-clés
Usage comparison
Compare the core capabilities of DotScript and Dr. Gupta
DotScript Core features
Dr. Gupta Core features
Use cases
DotScript Use cases
Dr. Gupta Use cases
DotScript vs Dr. Gupta:In-depth comparison and selection guidance
First decide whether the products solve the same kind of need
This in-depth DotScript vs Dr. Gupta comparison uses only the product records, taxonomy, audience, traffic, and community signals available on this page. DotScript is primarily listed under “Recherche”, while Dr. Gupta is primarily listed under “Assistant Médical”, so the first decision is whether your actual task matches their recorded scope.
The structured fields currently show these decision-relevant differences: Primary category (DotScript: Recherche; Dr. Gupta: Assistant Médical); Pricing (DotScript: Free; Dr. Gupta: Freemium); Monthly visits (DotScript: 3.6K; Dr. Gupta: 3.3K); Favorites (DotScript: 98; Dr. Gupta: 122); Website (DotScript: dotscript.netlify.app; Dr. Gupta: www.drgupta.ai). These facts are more useful for selection than brand visibility alone.
What market visibility and monthly traffic mean
In the DotScript vs Dr. Gupta monthly traffic comparison, DotScript currently shows 3.6K visits and Dr. Gupta shows 3.3K; the two products have similar visible traffic, an absolute difference of about 264 visits. This reflects visible reach, not feature quality or paid users.
Only Dr. Gupta has complete third-party traffic details; DotScript uses visits recorded inside ToolMage. These scopes cannot estimate market share directly, and on-site views should not be treated as the product’s total website traffic.
The current traffic scope is not sufficient for a reliable product ranking. Treat monthly visits as a market-interest signal, then decide using taxonomy, use cases, pricing, and a like-for-like trial rather than reading exposure as product capability.
Product positioning, use cases, and roles
DotScript and Dr. Gupta currently overlap in shared categories: Chatbot; shared tags: assistant de santé, chatbot médical et Vérificateur de symptômes. This can place both on the same shortlist, but it does not prove equal implementation, depth, or cost.
DotScript's unique categories/tags are Recherche, Médecine, Outil d'IA gratuit, Requêtes génétiques, génétique, informations sur la santé et recherche médicale; Dr. Gupta's are Assistant Médical, Vérificateur de symptômes, Médecin IA, informations médicales, santé des animaux de compagnie, IA Vétérinaire et médecin virtuel. These unique fields are the strongest differentiators: validate the product whose recorded scope matches the task instead of following traffic alone.
What ratings, comments, and favorites can tell you
DotScript has no verified rating, 0 comments, 98 favorites, and 94 likes;Dr. Gupta has no verified rating, 0 comments, 122 favorites, and 115 likes。
Neither product has enough rating or comment samples for a credible reputation ranking.
Selection guidance by actual need
When to evaluate DotScript first
Put DotScript on the priority trial list when the task aligns with “Recherche” and especially Recherche, Médecine, Outil d'IA gratuit, Requêtes génétiques, génétique et informations sur la santé. This follows recorded positioning and does not imply unlisted capabilities are absent.
DotScript also currently records: pricing is free, product type is website, 3.6K on-site monthly views, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
When to evaluate Dr. Gupta first
Put Dr. Gupta on the priority trial list when the task aligns with “Assistant Médical” and especially Assistant Médical, Vérificateur de symptômes, Médecin IA, informations médicales, santé des animaux de compagnie et IA Vétérinaire. This follows recorded positioning and does not imply unlisted capabilities are absent.
Dr. Gupta also currently records: pricing is freemium, product type is website, 3.3K verified monthly visits, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
How to validate the recommendation before deciding
The available data describes positioning, public visibility, and community signals, but it cannot prove output quality, speed, integration effort, privacy, or long-term cost in your workflow. Before deciding, run the same representative tasks in DotScript and Dr. Gupta, then record completion time, accuracy, manual corrections, and the real paid threshold. A like-for-like trial turns this comparison into a defensible adoption decision.




